Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mary E. Hall"'
Autor:
Mary E. Hall, Whitney J. Padgett, Zachary Klaassen, Diana E. Magee, Amy N. Luckenbaugh, Aaron A. Laviana, Raj Satkunasivam, Kerry Schaffer, Christopher J.D. Wallis
Publikováno v:
Clinical Genitourinary Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cf8870af65de0ce3d3fcbb412e27ba6
https://doi.org/10.1016/j.clgc.2023.04.007
https://doi.org/10.1016/j.clgc.2023.04.007
Autor:
Zachary Klaassen, Raj Satkunasivam, Mary E. Hall, Amy N. Luckenbaugh, Christopher J.D. Wallis, Brian I. Rini, Aaron A. Laviana, Kelvin A. Moses, Bimal Bhindi
Publikováno v:
Cancer Causes & Control. 32:675-680
Cytoreductive nephrectomy (CN) has played a role in treatment of metastatic renal cell carcinoma (mRCC) since trials demonstrated a survival benefit in patients receiving CN with interferon. With the publication of CARMENA, it became clear that the v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b58b845647caa12637c75fdd1c38481d
https://doi.org/10.1007/s10552-021-01435-z
https://doi.org/10.1007/s10552-021-01435-z
Autor:
Amy N. Luckenbaugh, Mary E. Hall, Christopher J.D. Wallis, Kelvin A. Moses, Aaron A. Laviana, Zachary Klaassen, Kirk A. Keegan, Heather L. Huelster
Publikováno v:
OncoTargets and Therapy. 13:3571-3581
Introduction The treatment landscape for patients with metastatic hormone-sensitive prostate cancer (mHSPC) has changed dramatically in the past five years, despite little change in the preceding 20 years. Such rapid change can make it difficult for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0411bdc96626932343964a84336c2fea
https://doi.org/10.2147/ott.s228355
https://doi.org/10.2147/ott.s228355
Publikováno v:
J Urol
INTRODUCTION: Active Surveillance (AS) for grade group 2 (GG2) patients is not yet well-defined. We sought to compare clinical outcomes of men with GG1 and GG2 prostate cancer undergoing AS in a large prospective North American cohort. METHODS: Parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd60311d92b6202080a4dfb857851160
https://pubmed.ncbi.nlm.nih.gov/34854745
https://pubmed.ncbi.nlm.nih.gov/34854745
Autor:
Kelvin A. Moses, Amy N. Luckenbaugh, Wilson Sui, Aaron A. Laviana, Daniel A. Barocas, Sam S. Chang, Mary E. Hall, Christopher J.D. Wallis, David F. Penson
Publikováno v:
Urology. 159
Objective To examine the relationship between hospital volume and the management of bladder cancer variant histology. Variant histologies of bladder cancer are rare which limits the ability for providers to develop expertise however there is a clear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf82815f3b2f452654adacdd14181769
https://pubmed.ncbi.nlm.nih.gov/34606878
https://pubmed.ncbi.nlm.nih.gov/34606878
Autor:
Diana Magee, Mohit Butaney, Merry W. Ma, Amy N. Luckenbaugh, Mary E. Hall, Nancy B. Davis, Christopher J.D. Wallis, Martha K. Terris, Aaron A. Laviana, Amanda Hird, Heather L. Huelster, Zachary Klaassen, Kyle Dymanus
Publikováno v:
CancerReferences. 127(17)
BACKGROUND Ensuring representative data accrual in clinical trials is important to safeguard the generalizability of results and to minimize disparities in care. This study's goal was to evaluate differences in gender representation in trials leading
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d174feaf1bbf52e3efcc9df5c1bda62a
https://pubmed.ncbi.nlm.nih.gov/34160824
https://pubmed.ncbi.nlm.nih.gov/34160824
Autor:
Martha K. Terris, Zachary Klaassen, Amy N. Luckenbaugh, Mary E. Hall, Christopher J.D. Wallis, Soum D. Lokeshwar, Rashid K. Sayyid, Amanda Hird, Caitlin E. Jones, Diana Magee
Publikováno v:
Journal of the American College of Surgeons. 233(2)
Background Female authorship opportunities have lagged behind those of their male counterparts, with gender disparities most prominent in surgical specialties. Our objective was to determine trends of female first, last, and first or last authorships
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9681c34a7bcfe1ee812cb0e50e223c3e
https://pubmed.ncbi.nlm.nih.gov/34304814
https://pubmed.ncbi.nlm.nih.gov/34304814
Autor:
Mary E, Hall, Bimal, Bhindi, Amy N, Luckenbaugh, Aaron A, Laviana, Kelvin A, Moses, Raj, Satkunasivam, Brian, Rini, Zachary, Klaassen, Christopher J D, Wallis
Publikováno v:
Cancer causescontrol : CCC. 32(7)
Cytoreductive nephrectomy (CN) has played a role in treatment of metastatic renal cell carcinoma (mRCC) since trials demonstrated a survival benefit in patients receiving CN with interferon. With the publication of CARMENA, it became clear that the v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d4fb883020c95ecdf3e8f2c14d87162
https://pubmed.ncbi.nlm.nih.gov/33963938
https://pubmed.ncbi.nlm.nih.gov/33963938
Autor:
Mary E. Hall, David F. Penson, Wilson Sui, Matthew J. Resnick, Aaron A. Laviana, Daniel A. Barocas, Sam S. Chang
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Upper tract urothelial carcinoma (UTUC) is a rare genitourinary malignancy that represents only 5-10% of all urothelial carcinoma (UC). While the majority of these cancer...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fee08a9b8b97a3ec63939a69cc1e777f
https://doi.org/10.1097/ju.0000000000000974.013
https://doi.org/10.1097/ju.0000000000000974.013
Autor:
Mary E. Hall, Christopher J.D. Wallis, Kelvin Lim, Kathryn E. Beckermann, Aaron A. Laviana, Amy N. Luckenbaugh, Antonio P. DeRosa, Zachary Klaassen, Brian I. Rini, Jonathan C.A. Guzman, Raj Satkunasivam
Publikováno v:
Urol Oncol
BACKGROUND: Immune checkpoint-inhibitor (ICI)-based therapy is the standard of care for first-line treatment of metastatic renal cell carcinoma (mRCC). It is unclear whether prior removal of the primary tumor influences the efficacy of these treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab0bbaf2ad6430e37d45d51e7c78061
https://doi.org/10.1016/j.urolonc.2021.09.009
https://doi.org/10.1016/j.urolonc.2021.09.009